MALANIL 250mg/100mg Tablet - Single Dose
Product Overview
MALANIL is a combination antimalarial medication containing Atovaquone (250 mg) and Proguanil hydrochloride (100 mg). It is primarily used for the prevention and treatment of malaria, particularly infections caused by Plasmodium falciparum, including strains that are resistant to other antimalarial drugs.
Conveniently formulated for easy oral administration, MALANIL offers a highly effective and well-tolerated option for both travelers and residents in malaria-endemic regions.
Key Features
- Active Ingredients: Atovaquone 250 mg and Proguanil hydrochloride 100 mg
- Formulation: Oral tablet
- Pack Size: 1 tablet per pack (single dose unit)
- Primary Actions:
- Prevents the development of malaria infection
- Treats active malaria infections caused by Plasmodium falciparum
- Effective against strains resistant to chloroquine and other antimalarials
- Dosage: As prescribed by a healthcare professional; often part of a multi-day course depending on the use (prevention vs. treatment)
Indications
- Prevention of malaria in travelers visiting endemic areas
- Treatment of acute uncomplicated malaria infections
Benefits
- High efficacy against resistant malaria strains
- Convenient once-daily dosing for prevention or full treatment courses
- Well tolerated with minimal side effects in most patients
- Suitable for both adults and children (with appropriate dosing adjustments)
Precautions and Warnings
- Should not be used in individuals with known hypersensitivity to atovaquone or proguanil.
- Consult a healthcare provider before use during pregnancy or breastfeeding.
- Patients with severe kidney problems should use MALANIL cautiously.
- Must be taken with food or a milky drink to enhance absorption.
Storage
- Store at room temperature (below 30°C).
- Protect from moisture and direct sunlight.
- Keep out of reach of children.